Crysvita (Generic Burosumab): Complete Medication Guide
Key Takeaways
Crysvita is a monoclonal antibody used to treat X-linked hypophosphatemia (XLH), a rare genetic disorder affecting phosphate and vitamin D metabolism.
It works by blocking FGF23, a hormone that causes the body to lose too much phosphate through urine.
Common side effects include injection site reactions, headaches, and ear-related symptoms.
This medication requires regular monitoring and typically involves subcutaneous injections every two weeks.
Treatment should always be managed by a healthcare provider experienced in rare bone disorders.
Crysvita (Generic Burosumab) Overview
Crysvita is a monoclonal antibody—a type of protein designed to target and block specific molecules in your body. The generic form, burosumab, works by inhibiting FGF23 (fibroblast growth factor 23), a hormone that plays a key role in how your body manages phosphate levels. In X-linked hypophosphatemia (XLH), FGF23 becomes overactive, causing your kidneys to waste too much phosphate in urine and preventing your body from properly absorbing and using vitamin D.
XLH is a rare inherited disorder that affects how your bones develop and harden. Without treatment, it can lead to rickets in children and bone pain, weakness, and deformities in adults. By blocking FGF23, Crysvita helps restore normal phosphate levels and improves bone mineralization. This medication represents a significant advancement in XLH treatment because it addresses the root cause of the disease rather than just managing symptoms with traditional phosphate and vitamin D supplements.
Understanding the difference between generic and brand-name drugs can help you make informed choices about your treatment. Generic burosumab contains the same active ingredient and works the same way as the brand-name Crysvita, often at a lower cost. This information is educational and does not replace advice from your healthcare provider.
Side Effects
Crysvita is generally well tolerated, but like all medications, it can cause side effects. Most people experience only mild to moderate effects, while others may have none at all. It's important to discuss any symptoms with your healthcare provider.
Common Side Effects
Injection site reactions — Redness, swelling, itching, or bruising at the spot where you receive your injection; these usually go away within a few hours to days.
Headaches — Mild to moderate headaches may occur; drinking water and resting can help.
Ear-related symptoms — Some patients report ear pain, hearing loss, or a feeling of fullness in the ear (hyperostosis of the ear canal is a known effect of XLH treatment).
Nausea — Mild stomach upset or nausea may happen; eating small meals can help.
Muscle or joint pain — Aches in muscles or joints may occur as your body adjusts to improved phosphate levels.
Fatigue — Mild tiredness has been reported by some patients.
Serious Side Effects
Severe allergic reactions — Difficulty breathing, chest tightness, or severe swelling of the face, lips, or throat require immediate medical attention.
Severe headache with fever — This combination may indicate a serious condition and needs urgent evaluation.
Signs of infection — Fever, chills, or unusual tiredness, especially if you develop symptoms after an injection.
Hearing loss — New or worsening hearing changes should be reported to your doctor immediately.
Vision changes — Any new eye problems or vision disturbances should be evaluated promptly.
When to Seek Medical Attention
Contact your healthcare provider right away if you experience severe headaches, sudden hearing loss, vision changes, signs of infection, or difficulty breathing. You should also report any new or concerning symptoms that develop during treatment. While serious side effects are uncommon, early detection and reporting help your medical team adjust your care as needed. Don't wait to reach out if you're concerned about any symptom.
Dosage
Patient Type |
Starting Dose |
Typical Maintenance Range |
Key Detail |
Children (under 18 years) |
0.3 mg/kg |
0.3–0.8 mg/kg |
Dosed based on body weight; adjusted every 4 weeks |
Adults |
0.8 mg/kg (max 90 mg) |
0.5–1.5 mg/kg |
Maximum starting dose is 90 mg; may increase every 4 weeks |
Renal Impairment |
Lower starting dose |
Individual adjustment |
Dosing adjusted based on kidney function; consult your doctor |
Maintenance Phase |
— |
Every 2 weeks |
Once stabilized, injections continue on a regular schedule |
Important: Never skip or stop Crysvita without talking to your doctor first. If you miss an injection, contact your healthcare provider for guidance on when to administer the next dose. Your doctor may adjust your dosing schedule based on lab results showing your phosphate and FGF23 levels. Always keep your appointments for blood work and follow-up visits so your medical team can monitor your progress.
Drug Interactions
Crysvita is a monoclonal antibody, which means it has a low risk of traditional drug-drug interactions. However, certain medications and supplements may affect how well your treatment works or increase the risk of side effects. Always inform your healthcare provider about all medications, supplements, and herbal products you're taking.
Phosphate and Vitamin D Supplements
Taking additional phosphate supplements while on Crysvita may raise your phosphate levels too high. Your doctor will monitor your levels and adjust supplementation as needed. Do not add or change these supplements without medical guidance.
NSAIDs (Nonsteroidal Anti-inflammatory Drugs)
Medications like ibuprofen and naproxen may increase the risk of kidney problems, especially in patients with XLH. Discuss pain management options with your healthcare provider before taking NSAIDs.
ACE Inhibitors and ARBs (Blood Pressure Medications)
These medications affect kidney function and may interact with Crysvita's effects on phosphate balance. Your doctor will monitor your kidney function closely if you take these drugs.
Loop Diuretics
Water pills that increase urine output may worsen phosphate loss. Your healthcare provider will carefully monitor electrolytes and adjust medications as needed if you require diuretics.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Targets the root cause — Unlike traditional supplements, Crysvita blocks FGF23 to address the underlying problem of XLH.
Improves bone health — Helps increase phosphate levels and improve bone mineralization and growth in children and adults.
Reduces symptoms — Decreases bone pain, improves strength, and can reduce deformities over time with consistent use.
Convenient dosing schedule — Injections are given every two weeks, making it easier to manage than frequent supplement doses.
Supported by research — Extensive clinical trials have demonstrated safety and effectiveness in treating XLH.
Cons
Requires regular injections — Subcutaneous injections every two weeks may be challenging for patients who dislike needles.
Requires close monitoring — Blood work and hearing tests must be done regularly to watch for complications.
Risk of hyperostosis — High phosphate levels can cause abnormal bone growth, requiring careful dose management.
Potential for hearing changes — Ear-related side effects are possible and need to be monitored.
Cost considerations — Though generic versions may be more affordable, the medication can still be expensive depending on your insurance coverage.
Frequently Asked Questions
Get answers to common questions about Crysvita (Generic Burosumab).
X-linked hypophosphatemia (XLH) is a rare genetic disorder where a faulty gene causes your body to lose too much phosphate through urine and fail to absorb enough vitamin D. Without treatment, this leads to weak, soft bones, short stature in children, and bone pain in adults. Early and consistent treatment with Crysvita can prevent serious skeletal complications and improve quality of life.
Most patients begin to see improvements in phosphate levels within a few weeks of starting Crysvita, with blood tests showing changes as early as 2–4 weeks. Bone health improvements, such as better bone strength and reduced pain, typically develop over months. Children may see improvements in growth and bone development within 3–6 months of consistent treatment.
Yes, generic medications are a cost-effective alternative to brand-name drugs and contain the same active ingredient. Discuss with your doctor whether switching makes sense for your situation. Some insurance plans may require you to try the generic version first. Both versions work the same way and have similar safety profiles.
Contact your healthcare provider immediately if you miss an injection. Depending on how long ago your last dose was, your doctor may have you take it as soon as possible or wait until your next scheduled injection. Do not double up on doses. Staying on schedule is important for keeping your phosphate levels stable and getting the best results.
XLH is a lifelong condition, and most patients continue Crysvita treatment indefinitely to maintain healthy phosphate levels and bone health. However, your doctor may adjust your dose or frequency as you age or if your condition changes. Regular check-ups help determine whether your current treatment plan is still right for you.
The Bottom Line
Crysvita (generic burosumab) represents a major breakthrough in treating X-linked hypophosphatemia by targeting the FGF23 hormone that causes phosphate loss. Unlike traditional supplements alone, this monoclonal antibody helps restore normal phosphate metabolism, improve bone health, and reduce symptoms of this rare genetic disorder. With regular monitoring and consistent injections every two weeks, many patients experience significant improvements in bone strength, growth, and quality of life. While side effects are usually mild and serious complications are rare, close attention to hearing and phosphate levels is essential. Working with a healthcare provider experienced in XLH ensures your treatment stays safe and effective. Ready to take control of your health with expert guidance? Get started with Doctronic today—our AI doctors offer 24/7 access to medical consultations with 99.2% treatment alignment with physicians, plus affordable video and text visits starting at just $19.
